1. Home
  2. DNLI vs PRDO Comparison

DNLI vs PRDO Comparison

Compare DNLI & PRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • PRDO
  • Stock Information
  • Founded
  • DNLI 2013
  • PRDO 1994
  • Country
  • DNLI United States
  • PRDO United States
  • Employees
  • DNLI N/A
  • PRDO N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • PRDO Other Consumer Services
  • Sector
  • DNLI Health Care
  • PRDO Real Estate
  • Exchange
  • DNLI Nasdaq
  • PRDO Nasdaq
  • Market Cap
  • DNLI 2.1B
  • PRDO 2.1B
  • IPO Year
  • DNLI 2017
  • PRDO N/A
  • Fundamental
  • Price
  • DNLI $13.92
  • PRDO $28.56
  • Analyst Decision
  • DNLI Strong Buy
  • PRDO Buy
  • Analyst Count
  • DNLI 15
  • PRDO 1
  • Target Price
  • DNLI $33.85
  • PRDO $40.00
  • AVG Volume (30 Days)
  • DNLI 1.5M
  • PRDO 680.8K
  • Earning Date
  • DNLI 08-04-2025
  • PRDO 07-31-2025
  • Dividend Yield
  • DNLI N/A
  • PRDO 1.81%
  • EPS Growth
  • DNLI N/A
  • PRDO N/A
  • EPS
  • DNLI N/A
  • PRDO 2.25
  • Revenue
  • DNLI N/A
  • PRDO $726,003,000.00
  • Revenue This Year
  • DNLI N/A
  • PRDO $24.62
  • Revenue Next Year
  • DNLI $323.34
  • PRDO $3.83
  • P/E Ratio
  • DNLI N/A
  • PRDO $12.78
  • Revenue Growth
  • DNLI N/A
  • PRDO 6.35
  • 52 Week Low
  • DNLI $10.57
  • PRDO $20.55
  • 52 Week High
  • DNLI $33.33
  • PRDO $34.60
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 45.66
  • PRDO 31.32
  • Support Level
  • DNLI $13.70
  • PRDO $28.23
  • Resistance Level
  • DNLI $14.60
  • PRDO $30.05
  • Average True Range (ATR)
  • DNLI 0.65
  • PRDO 0.75
  • MACD
  • DNLI -0.06
  • PRDO -0.14
  • Stochastic Oscillator
  • DNLI 13.13
  • PRDO 10.44

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About PRDO Perdoceo Education Corporation

Perdoceo Education Corp is an American for-profit education company that focuses on quality postsecondary education online to a diverse student population, along with campus-based and blended learning programs. The company's important segments include the American InterContinental University, the University of St. Augustine for Health Sciences, and Colorado Technical University. These universities provide undergraduate, graduate, and doctoral degree programs focusing on business, technology, management, and social services, with the majority of the students enrolled in programs offered fully online. The majority of the company's revenue comes from the Colorado Technical University segment.

Share on Social Networks: